Abstract
Pharmacogenomics, a fascinating, emerging area of biomedical research is strongly influenced by growing availability of genomic databases, high-through-put genomic technologies, bioinformatic tools and artificial computational modeling approaches. Multinational clusters, such as the regional and internet-driven pharmaco-grids generated an entirely new environment for research and development in pharmacology. Although the field of pharmacogenomics is in its infancy, the promise of pharmacogenomics lies in its potential to predict genomic sources of interindividual variability in drug response (both efficacy and toxicity), thus allowing individualization of therapy to maximize effectiveness and minimize risk. Thus, pharmacogenomics holds the promise for individualized medicine adapted to each persons own genetic makeup. Environmental factors including diet, age, and lifestyle as well as infection can influence a persons response to medicines, but understanding an individuals genetic background is thought to be the key to creating personalized drugs with greater efficacy and safety. Similar to other biomedical fields, in allergic and autoimmune diseases pharmacogenomics combines traditional pharmaceutical sciences such as biochemistry with annotated knowledge of genes, proteins, and single nucleotide polymorphisms (SNP). One of the major challenges now are developing and applying the statistical and computational capacity to store, manage, analyze and interpret the wealth of data being generated. This review summarizes the recent pharmacogenomic trends in inflammatory diseases with particular attention to autoimmune conditions and asthma.
Keywords: Pharmacogenomics, asthma, autoimmunity, single nucleotide polymorphism
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Genomic Strategies in Pharmacology of Asthma and Autoimmunity
Volume: 5 Issue: 4
Author(s): C. Szalai, E. I. Buzas, A. K. Fulop, L. Kohidai and A. Falus
Affiliation:
Keywords: Pharmacogenomics, asthma, autoimmunity, single nucleotide polymorphism
Abstract: Pharmacogenomics, a fascinating, emerging area of biomedical research is strongly influenced by growing availability of genomic databases, high-through-put genomic technologies, bioinformatic tools and artificial computational modeling approaches. Multinational clusters, such as the regional and internet-driven pharmaco-grids generated an entirely new environment for research and development in pharmacology. Although the field of pharmacogenomics is in its infancy, the promise of pharmacogenomics lies in its potential to predict genomic sources of interindividual variability in drug response (both efficacy and toxicity), thus allowing individualization of therapy to maximize effectiveness and minimize risk. Thus, pharmacogenomics holds the promise for individualized medicine adapted to each persons own genetic makeup. Environmental factors including diet, age, and lifestyle as well as infection can influence a persons response to medicines, but understanding an individuals genetic background is thought to be the key to creating personalized drugs with greater efficacy and safety. Similar to other biomedical fields, in allergic and autoimmune diseases pharmacogenomics combines traditional pharmaceutical sciences such as biochemistry with annotated knowledge of genes, proteins, and single nucleotide polymorphisms (SNP). One of the major challenges now are developing and applying the statistical and computational capacity to store, manage, analyze and interpret the wealth of data being generated. This review summarizes the recent pharmacogenomic trends in inflammatory diseases with particular attention to autoimmune conditions and asthma.
Export Options
About this article
Cite this article as:
Szalai C., Buzas I. E., Fulop K. A., Kohidai L. and Falus A., Genomic Strategies in Pharmacology of Asthma and Autoimmunity, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2006; 5 (4) . https://dx.doi.org/10.2174/187152306778772847
DOI https://dx.doi.org/10.2174/187152306778772847 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
On the Genetics of Innate Immunity in Crohns Disease
Current Genomics Screening of Anti-Histaminic Activity of Fagonia Schweinfurthii Hadidi in Guinea Pig Ileum and Formulate Anti-Histaminic Syrup
The Natural Products Journal Peptoids: Bio-Inspired Polymers as Potential Pharmaceuticals
Current Pharmaceutical Design Effectiveness of Long-Term Macrolide Therapy in Cryptogenic Organising Pneumonia
Current Respiratory Medicine Reviews The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Cellular Membranes and Lipid-Binding Domains as Attractive Targets for Drug Development
Current Drug Targets Can Untargeted Metabolomics Be Utilized in Drug Discovery/Development?
Current Topics in Medicinal Chemistry Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Claims of Current Inhaled Corticosteroid Patents for Treating Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Malononitrile as a Key Reagent in Multicomponent Reactions for the Synthesis of Pharmaceutically Important Pyridines
Current Organic Chemistry Allergy After Inhalation and Ingestion of Cereals Involve Different Allergens in Allergic and Celiac Disease
Recent Patents on Inflammation & Allergy Drug Discovery Hypersensitivity Reactions to Anticoagulant Drugs
Current Pharmaceutical Design Pharmacological Evaluation of Antiasthmatic Activity of Myrica nagi Bark Extracts
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry High Yield Immobilization and Stabilization of Oxidoreductases Using Magnetic Nanosupports and Their Potential Applications: An Update
Current Catalysis How to Measure Exercise Performance
Current Respiratory Medicine Reviews Current Update on Eosinophilic Lung Diseases and Anti-IL-5 Treatment
Recent Patents on Anti-Infective Drug Discovery Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’
Current Pharmaceutical Design Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets The Discovery of CDP323, a Potent Alpha4 Integrin Antagonist
Current Immunology Reviews (Discontinued) Pulmonary Disease in Beta-Thalassemia
Current Respiratory Medicine Reviews